SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 75.31 |
| Enterprise Value ($M) | -30.17 |
| Book Value ($M) | 211.53 |
| Book Value / Share | 2.57 |
| Price / Book | 0.36 |
| NCAV ($M) | 171.88 |
| NCAV / Share | 2.09 |
| Price / NCAV | 0.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.51 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.64 |
| Current Ratio | 10.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 206.32 |
| Assets | 245.96 |
| Liabilities | 34.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G/A | Tang Capital Management Llc | 9.97 | ||
| 13G/A | Commodore Capital Lp | 0.00 | -100.00 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 7.95 | |
| 13G/A | Cowen Financial Products LLC | 0.00 | -100.00 | |
| 13G/A | Millennium Management Llc | 2.40 | -50.36 | |
| 13G/A | Morgan Stanley | 1.40 | -60.08 | |
| 13D/A | Orbimed Advisors Llc | 11.90 | 0.00 | |
| 13G/A | Tang Capital Partners Lp | 7.80 | 159.74 | |
| 13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 3.00 | -3.24 | |
| 13D/A | Carlyle Group Inc. | 4.10 | 42.14 | |
| 13G/A | State Street Corp | 1.48 | -71.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 367,753 | 1,158,763 | 31.74 | |
| 215,390 | 816,517 | 26.38 | |
| 280,396 | 948,471 | 29.56 | |
| 51,660 | 593,692 | 8.70 | |
| 123,251 | 665,033 | 18.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACIU – AC Immune SA | ACRV – Acrivon Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io